- Pfizer Says Patients Who Relapse After Covid Pill Can Take More Bloomberg
- Paxlovid prescriptions to treat Covid increased tenfold in U.S. since late February, Pfizer says CNBC
- Pfizer confident in COVID pill Paxlovid’s $22B sales potential FiercePharma
- Paxlovid Is Here: A Pharmacist’s Prescribing Pearls Medscape
- Vaccine makers extend gains as Pfizer keeps 2022 COVID sales guidance intact Seeking Alpha
- View Full Coverage on Google News